Erlotinib - Wikipedia
Erlotinib, sold under the brand name Tarceva among others, is a medication used to treat non-small cell lung cancer (NSCLC) and pancreatic cancer. [4] .
Erlotinib: Uses, Dosage, Side Effects, Warnings - Drugs.com
2023年4月4日 · Erlotinib is a type of targeted therapy used to treat cancer. Erlotinib is a tyrosine kinase inhibitor that works by blocking the kinase activity of a protein called epidermal growth …
厄洛替尼 - 维基百科，自由的百科全书
厄洛替尼 （英語： erlotinib）以Tarceva（中文譯名"得舒緩"或"特羅凱"）等品牌於市面銷售，是一種用於治療 非小細胞肺癌 （英语：non-small-cell lung cancer） （NSCLC）和 胰臟癌 的藥 …
特罗凯（Tarceva，Erlotinib，厄洛替尼）FDA官方说明书 - 知乎
2005年11月2日 · 特罗凯是一种激酶抑制剂适用于： （1）用基于铂类一线化疗4个疗程没有进展局部晚期或转移性非-小细胞肺癌 (NSCLC)患者的维持治疗。 (1.1) （2）局部晚期或转移性非-小 …
Erlotinib (Tarceva) | FDA
On October 18, 2016, the U.S. Food and Drug Administration modified the indication for erlotinib (TARCEVA, Astellas Pharm Global Development Inc.) for treatment of non-small cell lung …
erlotinib oral: Uses, Side Effects, Interactions, Pictures ... - WebMD
Erlotinib is used to treat lung and pancreatic cancer. It works by slowing or stopping the growth of cancer cells. Take this medication by mouth on an empty stomach (at least 1 hour before or 2...
厄洛替尼_百度百科
厄洛替尼可试用于两个或两个以上化疗方案失败的局部晚期或转移的非小细胞肺癌的三线治疗。 本适应症是基于前述国外一项Ⅲ期临床研究结果得出。 对于中国人非小细胞肺癌二线治疗的疗 …
盐酸厄洛替尼 (Erlotinib Hydrochloride) - 药物靶点：EGFR x EGFR …
Erlotinib is now the treatment of choice for children and adults with Olmsted syndrome. Erlotinib is thought to inhibit formation of a complex that includes TRPV3, EGFR, and its primary skin …
Erlotinib: MedlinePlus Drug Information
Erlotinib is used to treat certain types of non-small cell lung cancer that has spread to nearby tissues or to other parts of the body in patients who have already been treated with at least …
Erlotinib - PubMed
Erlotinib (OSI-774), marketed by Genentech as Tarceva®, is anticancer drug approved by US-FDA for the treatment of Non-Small Cell Lung Cancer (NSCLC) and Pancreatic Cancer. …